Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

NCT01482585 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01482585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01482585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2011
Completion date
December 31, 2016
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma